A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease
Public ClinicalTrials.gov record NCT00960531. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Multicenter, Randomized, Third-party Un-blinded, Long-term Extension Study To Determine Safety, Tolerability, And Immunogenicity Of Acc-001 With Qs-21 Adjuvant In Subjects With Mild To Moderate Alzheimer Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the long term safety, tolerability, and immunogenicity of ACC-001, an investigational vaccine, plus QS-21 in subjects with mild to moderate Alzheimer's disease.
Study identification
- NCT ID
- NCT00960531
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Interventions
- ACC-001+ QS21 (3mcg) Biological
- ACC-001 (10 mcg) + QS-21 Biological
- ACC-001+QS-21 (30mcg) Biological
Biological
Eligibility (public fields only)
- Age range
- 50 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2009 (Type not available)
- Primary completion
- Dec 2013 (Actual)
- Completion
- Dec 2013 (Actual)
- Last update posted
- Apr 1, 2016
2009 – 2013
United States locations
- U.S. sites
- 28
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Alzheimer's Institute | Phoenix | Arizona | 85006 | — |
| Banner Boswell Medical Center | Sun City | Arizona | 85351 | — |
| Banner Sun Health Research Institute | Sun City | Arizona | 85351 | — |
| University of California San Francisco | San Francisco | California | 94117 | — |
| University of California, San Francisco | San Francisco | California | 94117 | — |
| University of California - San Francisco | San Francisco | California | 94143 | — |
| University of California San Francisco | San Francisco | California | 94158 | — |
| University of California, San Francisco | San Francisco | California | 94158 | — |
| Yale New Haven Hospital | New Haven | Connecticut | 06510 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06510 | — |
| Yale-New Haven Hospital | New Haven | Connecticut | 06511 | — |
| General Clinical Research Unit | Washington D.C. | District of Columbia | 20007 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20057 | — |
| MD Clinical | Hallandale | Florida | 33009 | — |
| Palm Beach Neurology - Premiere Research Institute | West Palm Beach | Florida | 33407 | — |
| Brigham and Woman's Hospital | Boston | Massachusetts | 02115 | — |
| Center for Alzheimer Research and Treatment | Boston | Massachusetts | 02115 | — |
| Barnes Jewish Hospital | St Louis | Missouri | 63108 | — |
| Washington University School of Medicine | St Louis | Missouri | 63108 | — |
| Barnes Jewish Hospital at Washington University | St Louis | Missouri | 63110 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Memory Enhancement Center of America, Inc. | Eatontown | New Jersey | 07724 | — |
| Columbia University/Taub Institute | New York | New York | 10032 | — |
| CUMC Research Pharmacy | New York | New York | 10032 | — |
| Butler Hospital | Providence | Rhode Island | 02906 | — |
| Southwestern Vermont Healthcare | Bennington | Vermont | 05201 | — |
| The Memory Clinic | Bennington | Vermont | 05201 | — |
| The Pharmacy, Inc | Bennington | Vermont | 05201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00960531, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 1, 2016 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00960531 live on ClinicalTrials.gov.